Ticker: BICX

BioCorRx Inc. (OTCMKTS: BICX) - quick read What's happening inside: BioCorRx completed an asset acquisition (Lucemyra) on March 4, 2025, recognized sizeable intangible assets and goodwill, began supply/distribution sales from that acquisition, continued NIH grant-funded R&D, and has been financin...

BioCorRx Inc. (OTCMKTS: BICX) has recently released its quarterly financial results for the period ending March 31, 2025. Here’s a concise overview of the key points from their income statement and operational insights: Revenue Growth: BioCorRx reported a net revenue of $134,899 for Q1 2025, a s...